In addition, the role and molecular mechanism of FASN in GC cells with AR were also investigated in vitro by controlling variables, the results of which demonstrated that FASN mediated AR in GC cells through p-ERK1/2/Bcl-xL pathway, making FASN as a promising therapeutic target for the intervention and remedy of metastasis in GC. This evidence concerns the gene MAPK3 and gastric cancer.